Fundraising Fox

PAVmed

NASDAQ: PAVM

New York, US · Founded 2014 · Delaware corporation

PAVmed is a medical technology company that develops and commercializes products across medical devices, diagnostics, and digital health through its subsidiaries. It serves healthcare systems, clinicians, and patients, with subsidiaries including Lucid Diagnostics (esophageal precancer and cancer detection) and Veris Health (remote patient monitoring for cancer care).

Digital HealthHealthtechMedical Devices

Founders & leadership

PAVmed was founded in 2014 by Michael J. Glennon, Lishan Aklog, Joshua R. Lamstein, and Brian Justo DeGuzman.

MJMichael J. Glennon
Michael J. GlennonCo-founder
LALishan Aklog
Lishan AklogCo-founder
JR
Joshua R. LamsteinCo-founder
BJ
Brian Justo DeGuzmanCo-founder
DMDennis M. McGrath
Dennis M. McGrathExecutive
MAMichael A. Gordon
Michael A. GordonExecutive
SOShaun O'Neil
Shaun O'NeilExecutive
RF
Richard FitzgeraldExecutive

Board

DJ
Debra J. WhiteBoard director
RM
Ronald M. SparksBoard director
SA
Sundeep AgrawalBoard director
TE
Timothy E. BaxterBoard director

Reported raises · per SEC filings

Form D private placements

$69.1M disclosed across 9 rounds · 2014–2026

▶$30MraisedFeb 2026 · 14 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Debra J. WhiteDirector
  • Lishan AklogExecutive Officer, Director
  • Michael A. GordonExecutive Officer
  • Ronald M. SparksDirector
  • Shaun O'NeilExecutive Officer
  • Sundeep AgrawalDirector
  • Michael J. GlennonDirector
  • Timothy E. BaxterDirector
  • Dennis M. McGrathExecutive Officer
Offering amount
$60M
Amount sold
$30M
First sale
Feb 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.7MraisedFeb 2025 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael J. GlennonDirector
  • Dennis M. McGrathExecutive Officer
  • Debra J. WhiteDirector
  • Michael A. GordonExecutive Officer
  • Ronald M. SparksDirector
  • Shaun O'NeilExecutive Officer
  • Sundeep AgrawalDirector
  • Timothy E. BaxterDirector
  • Lishan AklogExecutive Officer, Director
Offering amount
$2.7M
Amount sold
$2.7M
First sale
Jan 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.8MraisedAug 2020 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Dennis M. McGrathExecutive Officer
  • Michael GlennonDirector
  • Lishan AklogExecutive Officer, Director
  • David S. Battleman, M.D.Director
  • James L CoxDirector
  • Richard YazbeckExecutive Officer
  • Ronald M. SparksDirector
  • David Scott Weild, IVDirector
  • Shaun O'NeilExecutive Officer
Offering amount
$7.8M
Amount sold
$7.8M
First sale
Aug 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.1MraisedMay 2020 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Lishan AklogExecutive Officer, Director
  • David Scott Weild, IVDirector
  • Michael GlennonDirector
  • Dennis M. McGrathExecutive Officer
  • Ronald M. SparksDirector
  • James L CoxDirector
  • Richard YazbeckExecutive Officer
  • David S. Battleman, M.D.Director
  • Shaun O'NeilExecutive Officer
Offering amount
$4.1M
Amount sold
$4.1M
Finders' fees
$120.3K
Placement agents
Maxim Group LLC
First sale
Apr 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$14MraisedNov 2019 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Lishan AklogExecutive Officer, Director
  • Michael GlennonDirector
  • James L. CoxDirector
  • Ronald M. SparksDirector
  • David Scott Weild, IVDirector
  • David S. Battleman, M.D.Director
  • Dennis M. McGrathExecutive Officer
  • Shaun O'NeilExecutive Officer
  • Richard YazbeckExecutive Officer
Offering amount
$14M
Amount sold
$14M
Finders' fees
$819K
Placement agents
Maxim Group LLC
First sale
Nov 2019
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.8MraisedJan 2019 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Dennis M. McGrathExecutive Officer
  • David S. Battleman, M.D.Director
  • Michael GlennonDirector
  • James L. Cox, M.D.Director
  • Lishan Aklog, M.D.Executive Officer, Director
  • Ronald M. SparksDirector
  • David Scott Weild, IVDirector
  • Brian J. DeGuzman, M.D.Executive Officer
Offering amount
$7.8M
Amount sold
$7.8M
Finders' fees
$455K
Placement agents
Maxim Group LLC
First sale
Dec 2018
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$500KraisedAug 2017 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • David Scott Weild, IVDirector
  • Ronald M. SparksDirector
  • Ira Scott GreenspanDirector
  • Lishan AklogExecutive Officer, Director
  • James L. CoxDirector
  • David S. Battleman, M.D.Director
  • Dennis M. McGrathExecutive Officer
  • Joshua R. LamsteinDirector
  • Michael GlennonDirector
Offering amount
$500K
Amount sold
$500K
First sale
Aug 2017
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedFeb 2017 · 13 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Ronald M. SparksDirector
  • Joshua R. LamsteinDirector
  • Richard FitzgeraldExecutive Officer
  • James L. CoxDirector
  • Lishan AklogExecutive Officer, Director
  • David Weild, IVDirector
  • Michael GlennonDirector
  • Ira Scott GrenspanDirector
Offering amount
$3M
Amount sold
$1.5M
Sales commissions
$105.6K
Placement agents
Xzerta Trading LLC d/b/a HCFP/Capital Markets
First sale
Jan 2017
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 8

by search overlap
Robinhood25 shared keywordsRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Seeking Alpha24 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
StockTwits20 shared keywordsStocktwits operates an online community platform where investors and traders share ideas, analysis, and trade discussions organized around stock tickers. The page presented is its community guidelines rather than a product description.
Perplexity20 shared keywordsAn AI-powered answer engine providing accurate, trusted, and real-time answers to questions.
Simply Wall St19 shared keywordsSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.
TipRanks19 shared keywordsFinancial analysis and stock research platform.
Public18 shared keywordsPublic is a trading platform that allows users to buy and sell cryptocurrencies including Bitcoin, Ethereum, and memecoins through accounts managed by Zero Hash LLC, a New York State-licensed virtual currency business.
TradingView18 shared keywordsTradingView is a charting platform and social network used by over 100 million traders and investors worldwide to analyze and trade across global financial markets. The platform provides tools for technical analysis, market data, and community collaboration for retail and institutional traders.

Companies competing with PAVmed for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Resultsprnewswire.com · Aug 2026PAVmed Q2 2026 slides: loss narrows as cash position weakens By Investing.cominvesting.com · Aug 2026PAVmed raises $45 million, restructures capital to eliminate convertible debt By Investing.cominvesting.com · Feb 2026PAVmed Announces Reverse Stock Splitprnewswire.com · Dec 2025

Frequently asked questions

What does PAVmed do?
PAVmed is a medical technology company that develops and commercializes products across medical devices, diagnostics, and digital health through its subsidiaries. It serves healthcare systems, clinicians, and patients, with subsidiaries including Lucid Diagnostics (esophageal precancer and cancer detection) and Veris Health (remote patient monitoring for cancer care).
Who founded PAVmed?
PAVmed was founded by Michael J. Glennon, Lishan Aklog, Joshua R. Lamstein, Brian Justo DeGuzman in 2014.
How much funding has PAVmed raised?
PAVmed has disclosed $69.1M raised across 9 rounds.
Where is PAVmed headquartered?
PAVmed is headquartered in New York, US.